Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Tracking of second primary melanomas in vemurafenib-treated patients.

Tracking of second primary melanomas in vemurafenib-treated patients. JAMA Dermatol. 2013 Apr; 149(4):488-90.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.